By Professor Alta Schutte

Preprints

Huang L; Xu X; Matsushita K; Brady TM; Appel LJ; Hoorn EJ; Schutte AE; Wu JHY; Tian M; Aminde LN; Trieu K; Neal B; Marklund M, 2026, The effects on global health outcomes of switching from regular salt to potassium-enriched salt: a modelling study, http://dx.doi.org/10.64898/2026.04.06.26350270

Xu X; Zeng L; Li Y; Barr M; Grafenauer S; Schutte AE, 2026, Whole grain and high fiber cereals and multimorbidity: A longitudinal study in 146,329 adults aged 45 years and over, http://dx.doi.org/10.21203/rs.3.rs-9182393/v1

Trivedi R; Chapman N; Falster MO; Moran AE; Schutte AE; Zhou B; Picone DS, 2026, Hypertension detection, treatment and control in young adults in Australia, http://dx.doi.org/10.64898/2026.01.27.26345008

Slater K; Clapham E; Beesley K; Halcomb E; Kostyrka B; Kouladjian O’Donnell L; Laranjo L; Lopez F; Sarkies M; Satheesh G; Sawan M; Stephen C; Stevens J; Trivedi R; Schutte AE; Chapman N, 2026, Developing implementation strategies to improve patient education for hypertension in primary care, http://dx.doi.org/10.64898/2026.01.12.25341587

Nyein PP; Haskelberg H; Martinello M; Lowe M; Goodman-Meza D; Avihingsanon A; Kelleher AD; Rodgers A; Schutte AE; Nnakelu EC; Byakwaga H; Trevillyan J; Losso M; Kumarasamy N; Azwa RISR; Kaplan R; Clifton B; Arnott C; Dharan NJ; Petoumenos K; Matthews GV, 2026, Optimizing Metabolic Management on Integrase-based ART (OPTIMAR): study protocol for a 2x2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk, http://dx.doi.org/10.21203/rs.3.rs-7648678/v1

Slater K; Clapham E; Beesley K; Bonner C; Halcomb E; Kostyrka B; O’Donnell LK; Laranjo L; Lopez F; Sarkies M; Satheesh G; Sawan M; Stephen C; Stevens J; Trivedi R; Schutte AE; Chapman N, 2025, Patient personas exemplifying behavioural barriers and enablers to patient education across the hypertension journey: A qualitative framework analysis, http://dx.doi.org/10.64898/2025.12.10.25341407

Deng J; Devaux A; Gianacas C; Schutte AE, 2025, Shop-to-Stop Hypertension Statistical Analysis Plan, http://dx.doi.org/10.1101/2025.10.30.25339100

Clapham E; Carmichael S; Picone D; Schutte A; Slater K; Stevens J; Nelson M; Schlaich M; Climie R; Tsuyuki R; Stergiou G; Campbell NRC; Chapman N, 2025, How and why do Australians obtain blood pressure devices for use at home? A mixed-methods study, http://dx.doi.org/10.1101/2025.02.27.24318446

Aminde LN; Agbor VN; Fongwen NT; Ngwasiri C; Nkoke C; Nji M; Dzudie A; Schutte A, 2024, High burden of non-adherence to blood pressure-lowering medications: meta-analysis of data from over 34,000 adults with hypertension in Sub-Saharan Africa, http://dx.doi.org/10.1101/2024.05.28.24308082

Plessis J; Lammertyn L; Schutte A; Nienaber-Rousseau C, 2024, Homocysteine, blood pressure and gene–diet interactions in relation to vascular function measures of Black South Africans, http://dx.doi.org/10.21203/rs.3.rs-4317982/v1

Sabapathy K; Mwita FC; Dauya E; Bandason T; Simms V; Dziva Chikwari C; Doyle A; Ross D; Shah A; Hayes R; Schutte A; Kranzer K; Ferrand RA, 2023, High prevalence of hypertension and high-normal blood pressure: findings from a large population-based survey of young adults in Zimbabwe, http://dx.doi.org/10.1101/2023.07.03.23292156

Sabapathy K; Cyprian F; Dauya E; Bandason T; Simms V; Dziva Chikwari C; Doyle A; Ross D; Shah A; Hayes RJ; Schutte AE; Kranzer K; Ferrand RA, 2023, High Prevalence of Hypertension and High-Normal Blood Pressure: Findings from a Large Population-Based Survey of Young Adults in Zimbabwe, http://dx.doi.org/10.2139/ssrn.4498400

Desson Z; Sharman J; Searles A; Schutte A; Delles C; Olsen M; Ordunez P; Hure A; Morton R; Figtree E; Webster J; Jennings G; Redfern J; Nicolls S; McNamara M; Deeming S; Doyle K; Ramanathan S, 2023, Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study, http://dx.doi.org/10.21203/rs.3.rs-2366159/v1

Fourie CMT; Roux SB-L; Smith W; Schutte AE; Breet Y; Mels CMC; Gafane-Matemane LF; Lammertyn L; Uys L; Burger A; Joseph JS; Goswami N; De Boever P; Strijdom H, 2020, Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: Baseline Profile, Rationale and Methods of the Longitudinal EndoAfrica-NWU Study, http://dx.doi.org/10.21203/rs.3.rs-29419/v3

Fourie CMT; Roux SB-L; Smith W; Schutte AE; Breet Y; Mels CMC; Gafane-Matemane LF; Lammertyn L; Uys L; Burger A; Joseph JS; Goswami N; De Boever P; Strijdom H, 2020, Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: Baseline Profile, Rationale and Methods of the Longitudinal EndoAfrica-NWU Study, http://dx.doi.org/10.21203/rs.3.rs-29419/v2

Fourie CMT; Roux SB-L; Smith W; Schutte AE; Breet Y; Mels CMC; Gafane-Matemane LF; Lammertyn L; Uys L; Burger A; Joseph JS; Goswami N; De Boever P; Strijdom H, 2020, Vascular Function and Cardiovascular Risk in a HIV Infected and HIV Free Cohort of African Ancestry: Baseline Profile, Rationale and Methods of the Longitudinal EndoAfrica-NWU Study, http://dx.doi.org/10.21203/rs.3.rs-29419/v1

Back to profile page